Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(100.0%)
2Total
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05211011Phase 4Unknown

Efficacy and Safety of Intravenous Fosfomycin in Prosthetic Joint Infection

Role: collaborator

NCT03260010Phase 4Unknown

Efficacy and Safety of Intravenous Fosfomycin in Prosthetic Joint Infection

Role: lead

NCT02853461Unknown

Biofilm Investigation on Bearing Components of Explanted Hip Joint Prosthesis

Role: collaborator

NCT02424903Unknown

European Prosthetic Joint Infection Cohort Study- Hip, Knee and Shoulder Prosthetic Joint Infection

Role: lead

All 4 trials loaded